Abstract
Leucovorin is one of the several chemically active reduced derivatives of folic acid. It is used as an antidote to folic acid antagonist. Lecovorin calcium inj U.S.P. contains calcium folinate which belongs to a group of vitamins, used as an antidote to the harmful effects of Methotrexate (MTX) therapy. In this investigation, the modulatory effects exerted by the Leucovorin against MTX induced genotoxicity in mice by using Chromosomal Aberrations (CA) and sperm morphology assays were tested. Three different doses of Leucovorin were selected and tested for their modulatory activity on the genotoxicity exerted by 20 mg/kg of MTX. The results of the present study indicate a significant decrease in the frequency of CA and sperm head abnormalities suggesting that the Leucovorin modulates the MTX induced genotoxicity in a dose dependent manner and it reveals its antitoxic nature and suggests using along with chemotherapeutic agents in cancer chemotherapy. These findings provide the future directions for the research on design and development of possible modulatory drugs containing Leucovorin.
Keywords: Leucovorin, Genotoxicity, Chromosomal aberrations, Sperm head abnormalities.
Letters in Drug Design & Discovery
Title:Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice
Volume: 11 Issue: 1
Author(s): Chandra Sekhar Singh Bhaludra, Adharvana Chari Murugulla, Chakrapani Pullagummi, Ajay kumar Polkampally and Roja Rani Anupalli
Affiliation:
Keywords: Leucovorin, Genotoxicity, Chromosomal aberrations, Sperm head abnormalities.
Abstract: Leucovorin is one of the several chemically active reduced derivatives of folic acid. It is used as an antidote to folic acid antagonist. Lecovorin calcium inj U.S.P. contains calcium folinate which belongs to a group of vitamins, used as an antidote to the harmful effects of Methotrexate (MTX) therapy. In this investigation, the modulatory effects exerted by the Leucovorin against MTX induced genotoxicity in mice by using Chromosomal Aberrations (CA) and sperm morphology assays were tested. Three different doses of Leucovorin were selected and tested for their modulatory activity on the genotoxicity exerted by 20 mg/kg of MTX. The results of the present study indicate a significant decrease in the frequency of CA and sperm head abnormalities suggesting that the Leucovorin modulates the MTX induced genotoxicity in a dose dependent manner and it reveals its antitoxic nature and suggests using along with chemotherapeutic agents in cancer chemotherapy. These findings provide the future directions for the research on design and development of possible modulatory drugs containing Leucovorin.
Export Options
About this article
Cite this article as:
Bhaludra Sekhar Singh Chandra, Murugulla Chari Adharvana, Pullagummi Chakrapani, Polkampally kumar Ajay and Anupalli Rani Roja, Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice, Letters in Drug Design & Discovery 2014; 11(1) . https://dx.doi.org/10.2174/15701808113109990052
DOI https://dx.doi.org/10.2174/15701808113109990052 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
It Takes Two to Tango: The Structure and Function of LIM, RING, PHD and MYND Domains
Current Pharmaceutical Design Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry Evaluation of the in vitro Antitumor Activity of Nanostructured Cyclotides in Polymers of Eudragit® L 100-55 and RS 30 D
Letters in Drug Design & Discovery Modulation of intracellular pH in human ovarian cancer.
Current Molecular Medicine Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Resveratrol and Analogues: A Review of Antioxidant Activity and Applications to Human Health
Recent Patents on Food, Nutrition & Agriculture Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer
Mini-Reviews in Medicinal Chemistry Resistance to Anti-VEGF Agents
Current Pharmaceutical Design Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Erythropoietin Enhances the Cytotoxic Effect of Hydrogen Peroxide on Colon Cancer Cells
Current Pharmaceutical Biotechnology Chemotherapy in Addition to Preoperative Radiotherapy in Locally Advanced Rectal Cancer – A Systematic Overview
Reviews on Recent Clinical Trials RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
Current Cancer Drug Targets Bioinformatics Approach for Data Capturing: The Case of Breast Cancer
Current Cancer Therapy Reviews GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future
Current Pharmaceutical Design Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) Decreased Expression and Altered Methylation of Syncytin-1 Gene in Human Placentas Associated with Preeclampsia
Current Pharmaceutical Design Syntheses and Preliminary Evaluation of Dual Target PET Probe [<sup>18</sup>F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Thalidomide Controls Adipose Tissue Inflammation Associated with High- Fat Diet-Induced Obesity in Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets Advances in Translational Pharmacological Investigations in Identifying and Validating Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets